- cafead   Sep 03, 2024 at 11:42: AM
via Valneva and Pfizer have reported positive data from the Phase II VLA15-221 clinical trial of a second booster dose of their Lyme disease vaccine candidate, VLA15, administered one year after the initial booster.
article source
article source